Stay Curious. Stay Connected.
MailNewsletters♡Donate Now
Sign up
*Password must be at least 8 characters and contain one uppercase letter, one lowercase letter, one number and one symbol.
Already have an account?
By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
Sign in to your profile
Forgot Password?
New to MPR News?
Welcome back
to news
for you
Reset Password

Enter the username on file and we'll send you a code to reset your password.

Still require assistance or not sure what your User Name is?
Welcome back
to news
for you
Email Verification

A verification code has been emailed to

Still awaiting the code?
Tiffany Hanssen

President Trump's actual power when it comes to drug pricing

Go Deeper.

Create an account or log in to save stories.

Log inCreate a free Account

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Show me!

Before he was elected, then-candidate Donald Trump promised to take on big pharma lobbyists and the prescription drug price-fixing he claimed consumers were paying the price for.

But what — if anything — can he do now that he's president?

MPR News host Kerri Miller talked with Walid Gellad, co-director of the University of Pittsburgh's Center for Pharmaceutical Policy and Prescribing, and MIT professor of economics Sara Ellison about drug pricing and what changes we may see to rising drug costs.

Hear their conversation by using the audio player above.